Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence